Human ovarian carcinoma cell lines
First Claim
Patent Images
1. A human ovarian carcinoma cell line designated SNU-251 (Deposit number:
- KCLRF-BP-00020) which has an in-frame 3-bp deletion at codons 255 and 256 in exon 7 of the p53 gene, a nonsense mutation of codon 1815 in exon 23 of the BRCA1 gene, and a missense mutation of codon 723 in exon 19 of the hMLH1 gene.
1 Assignment
0 Petitions
Accused Products
Abstract
A human ovarian carcinoma cell line having an in-frame 3-bp deletion at codons 255 and 256 in exon 7 of the p53 gene, a nonsense mutation of codon 1815 in exon 23 of the BRCA1 gene, and a missense mutation of codon 723 in exon 19 of the hMLH1 gene.
1 Citation
1 Claim
-
1. A human ovarian carcinoma cell line designated SNU-251 (Deposit number:
- KCLRF-BP-00020) which has an in-frame 3-bp deletion at codons 255 and 256 in exon 7 of the p53 gene, a nonsense mutation of codon 1815 in exon 23 of the BRCA1 gene, and a missense mutation of codon 723 in exon 19 of the hMLH1 gene.
Specification
-
- Resources
Litigation Campaign Assessment
Thank you for your request. You will receive a custom alert email when the Litigation Campaign Assessment is available.
×
-
Current AssigneeJae-Gahb Park
-
Original AssigneeJae-Gahb Park
-
InventorsPark, Jae-Gahb, Yuan, Ying, Han, Hye-Seung, Kim, Woo-Ho, Kang, Soon-Beom, Park, Hyun-Sook, Lee, Jae-Ho, Chung, June-Key
-
Primary Examiner(s)Degen, Nancy
-
Assistant Examiner(s)SCHWARTZMAN, ROBERT A
-
Application NumberUS09/136,745Time in Patent Office384 DaysField of Search435/366, 435/371US Class Current435/371CPC Class CodesC12N 2500/25 Insulin-transferrin; Insuli...C12N 2501/11 Epidermal growth factor [EGF]C12N 2501/39 Steroid hormonesC12N 2501/395 Thyroid hormonesC12N 5/0693 Tumour cells; Cancer cells
